Skip to main content

Recombinant Human RUNX1T1/ETO/CDR protein is a Human Fragment protein, in the 38 to 604 aa range, expressed in Wheat germ and suitable for SDS-PAGE, ELISA, WB.

Be the first to review this product! Submit a review

Images

SDS-PAGE - Recombinant Human RUNX1T1/ETO/CDR protein (AB152255), expandable thumbnail

Key facts

Expression system
Wheat germ
Tags
Tag free
Applications
SDS-PAGE, ELISA, WB
Biologically active
No

Amino acid sequence

M P D S P V D V K T Q S R L T P P T M P P P P T T Q G A P R T S S F T P T T L T N G T S H S P T A L N G A P S P P N G F S N G P S S S S S S S L A N Q Q L P P A C G A R Q L S K L K R F L T T L Q Q F G N D I S P E I G E R V R T L V L G L V N S T L T I E E F H S K L Q E A T N F P L R P F V I P F L K A N L P L L Q R E L L H C A R L A K Q N P A Q Y L A Q H E Q L L L D A S T T S P V D S S E L L L D V N E N G K R R T P D R T K E N G F D R E P L H S E H P S K R P C T I S P G Q R Y S P N N G L S Y Q P N G L P H P T P P P P Q H Y R L D D M A I A H H Y R D S Y R H P S H R D L R D R N R P M G L H G T R Q E E M I D H R L T D R E W A E E W K H L D H L L N C I M D M V E K T R R S L T V L R R C Q E A D R E E L N Y W I R R Y S D A E D L K K G G G S S S S H S R Q Q S P V N P D P V A L D A H R E F L H R P A S G Y V P E E I W K K A E E A V N E V K R Q A M T E L Q K A V S E A E R K A H D M I T T E R A K M E R T V A E A K R Q A A E D A L A V I N Q Q E D S S E S C W N C G R K A S E T C S G C N T A R Y C G S F C Q H K D W E K H H H I C G Q T L Q A Q Q Q G D T P A V S S S V T P N S G A G S P M D T P P A A T P R S T T P G T P S T I E T T P R

Reactivity data

Application
SDS-PAGE
Reactivity
Reacts
Dilution info
-
Notes

-

Application
ELISA
Reactivity
Reacts
Dilution info
-
Notes

-

Application
WB
Reactivity
Reacts
Dilution info
-
Notes

-

Target data

Function

Transcriptional corepressor which facilitates transcriptional repression via its association with DNA-binding transcription factors and recruitment of other corepressors and histone-modifying enzymes (PubMed:10688654, PubMed:12559562, PubMed:15203199). Can repress the expression of MMP7 in a ZBTB33-dependent manner (PubMed:23251453). Can repress transactivation mediated by TCF12 (PubMed:16803958). Acts as a negative regulator of adipogenesis (By similarity). The AML1-MTG8/ETO fusion protein frequently found in leukemic cells is involved in leukemogenesis and contributes to hematopoietic stem/progenitor cell self-renewal (PubMed:23812588).

Alternative names

Recommended products

Recombinant Human RUNX1T1/ETO/CDR protein is a Human Fragment protein, in the 38 to 604 aa range, expressed in Wheat germ and suitable for SDS-PAGE, ELISA, WB.

Key facts

Expression system
Wheat germ
Applications
SDS-PAGE, ELISA, WB
Accession
Q06455-1
Animal free
No
Species
Human
Concentration
Loading...
Storage buffer

pH: 8
Constituents: 0.79% Tris HCl, 0.31% Glutathione

Sequence info

Amino acid sequence

M P D S P V D V K T Q S R L T P P T M P P P P T T Q G A P R T S S F T P T T L T N G T S H S P T A L N G A P S P P N G F S N G P S S S S S S S L A N Q Q L P P A C G A R Q L S K L K R F L T T L Q Q F G N D I S P E I G E R V R T L V L G L V N S T L T I E E F H S K L Q E A T N F P L R P F V I P F L K A N L P L L Q R E L L H C A R L A K Q N P A Q Y L A Q H E Q L L L D A S T T S P V D S S E L L L D V N E N G K R R T P D R T K E N G F D R E P L H S E H P S K R P C T I S P G Q R Y S P N N G L S Y Q P N G L P H P T P P P P Q H Y R L D D M A I A H H Y R D S Y R H P S H R D L R D R N R P M G L H G T R Q E E M I D H R L T D R E W A E E W K H L D H L L N C I M D M V E K T R R S L T V L R R C Q E A D R E E L N Y W I R R Y S D A E D L K K G G G S S S S H S R Q Q S P V N P D P V A L D A H R E F L H R P A S G Y V P E E I W K K A E E A V N E V K R Q A M T E L Q K A V S E A E R K A H D M I T T E R A K M E R T V A E A K R Q A A E D A L A V I N Q Q E D S S E S C W N C G R K A S E T C S G C N T A R Y C G S F C Q H K D W E K H H H I C G Q T L Q A Q Q Q G D T P A V S S S V T P N S G A G S P M D T P P A A T P R S T T P G T P S T I E T T P R
Accession
Q06455
Protein length
Fragment
Predicted molecular weight
88 kDa
Amino acids
38 to 604
Nature
Recombinant

Specifications

Form
Liquid

General info

Function

Transcriptional corepressor which facilitates transcriptional repression via its association with DNA-binding transcription factors and recruitment of other corepressors and histone-modifying enzymes (PubMed:10688654, PubMed:12559562, PubMed:15203199). Can repress the expression of MMP7 in a ZBTB33-dependent manner (PubMed:23251453). Can repress transactivation mediated by TCF12 (PubMed:16803958). Acts as a negative regulator of adipogenesis (By similarity). The AML1-MTG8/ETO fusion protein frequently found in leukemic cells is involved in leukemogenesis and contributes to hematopoietic stem/progenitor cell self-renewal (PubMed:23812588).

Sequence similarities

Belongs to the CBFA2T family.

Subcellular localisation
Nucleus

Storage

Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-80°C
Appropriate long-term storage conditions
-80°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Notes

This product was previously labelled as RUNX1T1 / ETO.

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.
Activity summary

RUNX1T1 also known as ETO or CDR is an important transcriptional regulator. It has a mass of approximately 70 kDa. This protein is expressed in various body tissues including hematopoietic cells. RUNX1T1 is heavily involved in transcriptional repression playing a role in chromatin remodeling and gene expression regulation. Structurally it binds to DNA through specific interactions which influences gene activation or repression contributing to the regulation of cell differentiation.

Biological function summary

The functions of RUNX1T1 involve its participation in the formation of transcriptional complexes. It interacts with several co-repressors and co-activators affecting gene transcription which is important for hematopoiesis. It regulates a range of gene expressions minimally necessary for normal blood cell development. These complexes enable RUNX1T1 to function in a tightly controlled way supporting tissue-specific gene expression and ensuring balance in cell proliferation and differentiation.

Pathways

RUNX1T1 has pivotal roles in the hematopoietic and differentiation pathways. It interacts with RUNX1 forming a RUNX1-RUNX1T1 fusion that disrupts normal blood cell development. This fusion alters its typical role in the regulation of gene transcription which intersects with other signaling pathways such as the TGF-beta pathway. RUNX1T1-ETO fusion is linked with important proteins involved in signaling and transcription processes which demonstrate its broad relevance within cellular growth pathways.

Associated diseases and disorders

RUNX1T1's misregulation or fusion with RUNX1 characterizes certain leukemias notably acute myeloid leukemia (AML). This fusion protein acts aberrantly in hematopoiesis contributing to the development of leukemic cells. Apart from leukemia abnormalities in RUNX1T1 function can also impact other disorders related with defects in blood cell development. The disease association highlights RUNX1T1's interaction with other oncogenic proteins like FLT3 influencing AML pathogenesis.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

1 product image

  • SDS-PAGE - Recombinant Human RUNX1T1/ETO/CDR protein (ab152255), expandable thumbnail

    SDS-PAGE - Recombinant Human RUNX1T1/ETO/CDR protein (ab152255)

    12.5% SDS-PAGE stained with Coomassie Blue.

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com